Phase 1 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with multiple myeloma, confirmed through a tissue test (biopsy).
- Your kidneys are not working at full capacity — specifically, your kidney filtering rate (eGFR) is below 45.
- You are 18 years of age or older.
- You are generally able to carry out normal daily activities with little to no limitation (confirm with trial site).
- You qualify for a specific cancer cell therapy called cilta-cel based on standard medical guidelines.
- Your white blood cell (neutrophil) count meets a minimum level; if it is low due to recent treatment, you may be re-tested during the screening period to check again.
- If you have previously had a stem cell transplant using your own cells, the transplant must have contained a sufficient number of stem cells (confirm with trial site for specific numbers).
- You must have enough of your own stored stem cells available, in case they are needed during treatment.
- If you are a woman who could become pregnant, or a man, you must agree to use reliable birth control throughout the study; you must tell your doctor immediately if pregnancy is suspected.
- You are willing and able to read and sign a consent form agreeing to take part; a legal representative may do this on your behalf if needed.
Who may not be able to join:
- You have another cancer (past or current) that could affect the safety of the treatment or make results harder to measure (confirm with trial site).
- You are currently taking part in another clinical trial involving an experimental treatment.
- You have an uncontrolled serious illness, such as an active infection, severe heart failure, unstable chest pain, or an unstable irregular heartbeat; heart function must meet a minimum standard to be eligible (confirm with trial site).
- You are currently pregnant or breastfeeding; women who could become pregnant must have a negative pregnancy test within 14 days of joining.
- You are HIV-positive and have not had an undetectable viral load for at least 6 months on effective HIV treatment.
- You have chronic hepatitis B virus (HBV) and your viral load is still detectable, even on suppressive treatment.
- You have a history of hepatitis C virus (HCV) that has not been cured, or your viral load is still detectable.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Michael J Slade, M.D., MSCI, Washington University School of Medicine
Phone: 314-454-8304
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of dose-limiting toxicities (DLTs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.